Загрузка...
Efficacy of Omalizumab in Indolent Systemic Mastocytosis
BACKGROUND: Systemic mastocytosis (SM) comprises a heterogeneous group of disorders characterized by the proliferation of clonal mast cells in skin and various internal organs. Omalizumab is an established, labelled therapy for allergic asthma and chronic urticaria, but its experience in the efficac...
Сохранить в:
| Опубликовано в: : | Case Rep Hematol |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Hindawi
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6766258/ https://ncbi.nlm.nih.gov/pubmed/31637065 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/3787586 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|